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Background
Naturally infected sooty mangabeys (SM) do not pro-
gress to AIDS unlike SIV-infected non-natural hosts
including rhesus macaques (RM). Differences in the
innate immune response to SIV may be critical in avoid-
ance of disease progression in SIV-infected SM. In this
study we investigated innate and adaptive immune
responses to recombinant HSV vectors expressing SIV
Gag, Env, and a Rev-Tat-Nef fusion protein in six SIV-
negative SM and four RM following single intramuscular
inoculation.
Methods
Plasma samples were analyzed using Luminex 28-plex
assay. Innate immune cells and SIV-specific cellular
immune responses were investigated by flow cytometry
and IFN-g ELISPOT assay.
Results
A significant transient decline of circulating Natural
Killer T (NKT) cells, pDCs, and NK cells was observed
in SM on day one post vaccination, with a return to
baseline levels by day 3-7. Also an increased activation
of SM NK cells was observed that returned to baseline
by day 9. In contrast, RM displayed no significant
change in circulating NKT cell and NK cell frequencies.
Both RM and SM exhibited similar transient increases
in plasma levels of several inflammatory cytokines/che-
mokines including IL-1RA, IFN-g,I L - 6 ,I L - 8 ,m a c r o -
phage migration inhibitory factor (MIF), monocyte
chemotactic protein 1 (MCP-1), vascular endothelial
growth factor (VEGF), and interferon-inducible T cell
alpha-chemoattractant (I-TAC) by day one, suggesting
activation of multiple immune cells including macro-
phages and DCs. By day 14, plasma levels of analytes
such as IL-6 and Eotaxin persisted at elevated levels in
RM, but not SM, suggesting delayed resolution of
immune activation in RM. SIV-specific cellular immune
responses were detected in both species.
Conclusion
These data confirm that SM mount a robust innate
immune response and do not have blunted immune
activation. Further investigation of the mechanism by
which SM resolve the transient but higher immune acti-
vation would be helpful in improving vaccine strategy.
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